Vencorex, the joint venture company operated by shareholders PTTGC and Perstorp, recently announced plans to strengthen its worldwide position in the manufacture and supply of speciality diisocyanates; HDI, IPDI, Tolonate & Easaqua grades and new products.
To achieve this long term ambition, Vencorex plans to enhance its footprint of production capabilities, commercial activities and R&D innovation towards the following configuration:
- Tolonate production facilities in three main continents ready to serve global markets. Vencorex already has these at Pont De Claix, France, and Freeport, TX, USA, but will add a new facility in Thailand, starting in 2015.
- Pont De Claix will continue to be the production hub of HDI and IPDI monomers with significantly larger capacity and expansion in new products.
- The global sales & marketing organisation will be strengthened to capture growth opportunities and better serve international customers.
- R&D capabilities in France will be further developed to support this strategy through the innovation of new products and applications.
With all these initiatives, Vencorex will therefore implement several industrial projects with the objective to sustain its position as a leading global partner for speciality isocyanates in the coming years.